FFCD - Prognostic Effect of BRAF and KRAS Mutations in Patients With Stage III Colon Cancer Treated With Leucovorin, Fluorouracil, and Oxaliplatin With or Without Cetuximab

Prognostic Effect of BRAF and KRAS Mutations in Patients With Stage III Colon Cancer Treated With Leucovorin, Fluorouracil, and Oxaliplatin With or Without Cetuximab

Auteurs

Julien Taieb, Aziz Zaanan, Karine Le Malicot, Catherine Julié, Hélène Blons, Laurent Mineur, Jaafar Bennouna, Josep Tabernero, Enrico Mini, Gunnar Folprecht, Jean Luc Van Laethem, Come Lepage, Jean-François Emile, Pierre Laurent-Puig

Journal / Conférence

JAMA Oncology

Type de publication

Article

Etude

PETACC 8

Localisation

Côlon